Wednesday, June 10, 2026

pharma Β· Hypoparathyroidism (HP) in Adults Β· Chronic hypoparathyroidism

Ascendis Pharma

Ascendis Pharma clinical programs β€” 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Palo Alto, USA HQ
2010 Founded
5 Employees
EMA registrant Type
Company details
Status
Public
HQ
Palo Alto, USA
Founded
2010
Employees
5
Programs
2
Drugs
3
Patents
12
Intelligence Β· Clinical Programs

Ascendis Pharma projects

1 ClinicalTrials.gov programs sponsored by Ascendis Pharma.

Ascendis Pharma has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. TransCon PTH

    Ascendis Pharma Bone Diseases A/S

    Hypoparathyroidism (HP) in Adults

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Ascendis Pharma have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.